Skip to main content

Kidney Stones clinical trials at University of California Health

8 in progress, 6 open to eligible people

Showing trials for
  • A Study of Ureteral Stent Placement After Ureteroscopy for Kidney Stones

    open to eligible people ages 18 years and up

    The rationale for this study is to determine if there is a difference in complications among patients undergoing ureteroscopy for renal stones who receive a stent compared to not receiving a stent postoperatively.

    at UC Davis UCLA UCSD

  • Asymptomatic Renal Calculi in Recurrent Urinary Tract Infections

    open to eligible people ages 18 years and up

    This study will assess patients who have recurrent urinary tract infections and kidney stones which are not blocking the kidney or causing other problems. Currently, we don't know if taking out these stones will improve recurrent urinary tract infections or not. Patients will make a decision with their surgeon about removing or monitoring their stone(s). Whether or not their infections continue with surgery or monitoring will be noted, and this information may help to inform future treatment decisions. The purpose of this study is to assess if treatment of these asymptomatic stones affects the rate of recurrent urinary tract infections.

    at UCSD

  • Evaluation of Pain Before and After Removal of Non-obstructive Kidney Stones

    open to eligible people ages 18 years and up

    Pain associated with renal stone disease is typically caused by an obstructing stone that obstructs the flow of urine, which results in renal collecting system dilatation. Non-obstructing renal calculi that do not cause renal collecting system dilatation are thought to be painless. The objective of this study is to prospectively determine if the removal of non-obstructing renal calculi can reduce or eliminate participant's pain and/or improve their quality of life.

    at UC Davis UCLA UCSD

  • MIP Versus PCNL for Kidney Stone Disease

    open to eligible people ages 18 years and up

    The decision to use standard percutaneous nephrolithotomy (PCNL) versus mini-percutaneous nephrolithotomy (MIP) has been a subject of much debate in the urological community. The investigators propose a randomized controlled trial to compare the operative outcomes and complications of mini-percutaneous nephrolithotomy (mini-PCNL) versus standard PCNL for renal stones. The results of this study will help guide the decision making regarding these two procedures in the US population and provide further insight into the utility and safety of these procedures. A cost analysis will be performed, and it is hypothesized that the reusable components of the Storz MIP set will result in lower costs of the mini-PCNL procedure compared to standard PCNL.

    at UCSD

  • Pediatric KIDney Stone (PKIDS) Care Improvement Network

    open to eligible people ages 8-21

    The goals of this study are to improve the ability of pediatric patients and their caregivers to select surgical treatment options for kidney stones and to enable urologists to use techniques that result in the best outcomes for these surgeries.

    at UCLA

  • Struvite Stones Antibiotic Study

    open to eligible people ages 19 years and up

    The aim of this research is to determine an effective antibiotic regimen following definitive surgical therapy of kidney stones caused by bacterial infection (struvite stones).

    at UCSD

  • Ambulatory Versus Inpatient Percutaneous Nephrolithotomy

    Sorry, not yet accepting patients

    The goal of the study is to determine if ambulatory tubeless PCNL is safe and effective compared to inpatient PCNL with a nephrostomy tube.

    at UCSF

  • Contrast-enhanced Ultrasound Versus CT Scan for Kidney Stone Patient Management

    Sorry, not yet accepting patients

    This study will be a randomized controlled study comparing the use of two clinical management strategies in nephrostomy tube management following percutaneous nephrolithotomy (PCNL). The first strategy entails using contrast-enhanced ultrasound (CEUS) to evaluate the renal collecting system (1). This is a new imaging approach applying ultrasound machines with special software in combination with intraluminal ultrasound contrast agent (Lumason) injection, which is an FDA-approved ultrasound contrast agent (2). The second strategy is a nephrostomy tube capping trial combined with low dose non-contrast computed tomography (CT) scan, one of the most frequently utilized clinical management strategies currently used in clinical practice (3).

    at UCSF

Last updated: